Generating Product IPR
Let Scantox propose how to develop your specific molecule into a unique proprietary product.
We have supported many customers in getting new IPR and thus new commercial potential by re-inventing their products into efficient combination products.
We offer the following services:
- Formulation Development to achieve products with unique dissolution profiles e.g. delayed and extended release products
- Combination products of several active drugs having different release profiles such as products where the individual drugs each are having a unique delivery profile
- Improved bioavailability of low soluble drugs
- Elimination of high first pass metabolism and/or CYP metabolism of lipohilic drugs
- Reduction or elimination of food effect
- Generation of product patent applications
For very lipophilic products with LogP >5, our proprietary Lymphatic Targeting Technology allows us to develop complete new and unique products showing excellent bioavailability by overcoming a high first pass metabolism and removing food effect. It is a strong desire for patients that their medicine can be taken independent of meals, a benefit often not possible today, – but where the Technology can make a difference.
All you need to know abot Scantox’ proprietary Lymphatic Targeting Technology.
Explore Other Scantox Services
For more information
…or discussions on other models, do not hesitate to contact us.